SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENSET - GENXY
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (107)11/3/2000 3:54:42 AM
From: nigel bates   of 200
 
"...The change in total revenues for the third quarter reflects the Company's shift in strategy away from entering into limited gene target discovery deals on behalf of pharmaceutical companies to a focus on developing products for its own benefit. As a result, research and development ("R&D") revenues decreased 42.7% to 2.9 million ($2.5 million), accounting for 46% of total revenues, while oligonucleotide sales increased 58.2% to 3.4 million ($3.0 million)...."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News